Simulations Plus, Inc. (SLP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 46.72 |
| Open | 47.00 |
| Bid | 46.66 x 100 |
| Ask | 46.81 x 100 |
| Day's range | 46.50 - 47.46 |
| 52-week range | 32.69 - 52.69 |
| Volume | |
| Avg. volume | 110,259 |
| Market cap | 933.295M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 89.81 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.51%) |
| Ex-dividend date | 26 Apr 2024 |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ...
On May 1, 2024, Walter Woltosz, Director and 10% Owner of Simulations Plus Inc (NASDAQ:SLP), sold 20,000 shares of the company.
- Simply Wall St.
Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
- Zacks
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
© 2024 Yahoo. All rights reserved.